Best Vanguard Biotech Etfs: Top Picks For Investors

The biotech industry is known for its cyclical, high-risk, high-reward nature, with companies relying on successful drug development to thrive. Vanguard Health Care ETFs offer a way to invest in the full spectrum of healthcare stocks, including biotech firms, and provide exposure to the entire healthcare value chain. Vanguard's ETFs in this sector track the performance of health care indices, aiming to replicate their composition. An example of this is the Vanguard Health Care Index Fund ETF Shares (VHT), which seeks to mirror the MSCI US IMI/Health Care 25/50 index. While Vanguard offers broad exposure to the healthcare sector, there are other ETFs specifically focused on biotech that offer a more targeted approach, such as the VanEck Biotech ETF (BBH) and the iShares Biotechnology ETF (IBB).

Vanguard Health Care ETFs

The Vanguard Health Care ETF (VHT) seeks to track the performance of the MSCI US Investable Market Index (IMI)/Health Care 25/50. This index is made up of stocks from large, mid-size, and small US companies within the healthcare sector, as classified under the GICS. The fund is non-diversified, aiming to replicate the target index by investing most of its assets in the stocks that comprise the index. As of 10:13 AM EDT, VHT had a YTD daily total return of 15.69% and an expense ratio (net) of 0.10%.

VHT's top 10 holdings include well-known companies such as Eli Lilly and Company (10.31%), UnitedHealth Group Incorporated (8.43%), AbbVie Inc. (5.20%), Johnson & Johnson (4.69%), and Merck & Co., Inc. (3.81%).

Biotech ETF diversification

The biotech industry is known for its cyclical, high-risk, high-reward nature, making diversification a valuable strategy. Biotech companies are heavily focused on research and development (R&D), requiring significant capital preservation during slow periods. As such, investing in the entire industry through exchange-traded funds (ETFs) is a more prudent approach than picking individual stocks.

Vanguard Health Care ETFs offer exposure to the full spectrum of healthcare stocks, including biotech and pharmaceutical manufacturers, medical device makers, benefits managers, insurance firms, and even medical real estate owners. The Vanguard Health Care Index Fund ETF Shares (VHT) is a notable example, tracking the performance of the MSCI US Investable Market Index (IMI)/Health Care 25/50. This index comprises stocks from large, mid-size, and small US healthcare companies.

For investors specifically seeking diversification within the biotech space, there are several biotech ETFs available from providers like VanEck, iShares, Invesco, SPDR, Global X, WisdomTree, and Direxion. These ETFs track various biotech and genomics indices, providing exposure to a diverse range of companies within the industry.

For instance, the VanEck Biotech ETF (BBH) tracks the MVIS US-Listed Biotech 25 Index, focusing on large and liquid US biotech firms. The iShares Biotechnology ETF (IBB) follows the NYSE Biotechnology Index, while the Invesco Nasdaq Biotechnology ETF (IBBQ) tracks the Nasdaq Biotechnology Index. The SPDR S&P Biotech ETF (XBI) employs a modified equal-weight approach, allocating equal investments across 136 holdings, including small and mid-cap biotech stocks.

Global X offers the Genomics & Biotechnology ETF (GNOM), which specifically includes firms that derive at least 50% of their revenue from key genomics biotech segments, such as gene editing and genomic sequencing. The WisdomTree BioRevolution Fund (WDNA) takes a complementary approach, investing in innovative megatrends in the biotech space, with a more global perspective.

In conclusion, the inherently volatile nature of the biotech industry makes diversification a prudent strategy. Vanguard Health Care ETFs provide broad exposure to the healthcare sector, including biotech. For investors specifically seeking diversification within biotech, several biotech-focused ETFs offer varied approaches to mitigate risk and capitalise on the industry's potential.

Vanguard Health Care Index Fund ETF

The Vanguard Health Care Index Fund ETF (VHT) is a great option for investors looking to gain exposure to the healthcare sector, including biotech and pharmaceutical manufacturers, medical device makers, insurance firms, and more. This exchange-traded fund (ETF) employs an indexing investment approach, tracking the performance of the MSCI US Investable Market Index (IMI)/Health Care 25/50. This index consists of stocks from large, mid-size, and small US companies within the healthcare sector, as classified under the GICS.

The fund's advisor attempts to replicate the index's performance by investing most of its assets in the stocks that comprise the index, holding each stock in approximately the same proportion as its weighting in the index. This fund is non-diversified, with a PE ratio (TTM) of 26.18, a YTD daily total return of 15.69%, a Beta (5Y Monthly) of 0.72, and an expense ratio (net) of 0.10%.

Some of the top holdings of the Vanguard Health Care Index Fund ETF include well-known healthcare companies such as Eli Lilly and Company (10.31%), UnitedHealth Group Incorporated (8.43%), AbbVie Inc. (5.20%), Johnson & Johnson (4.69%), and Merck & Co., Inc. (3.81%).

By investing in this ETF, individuals can gain exposure to a diverse range of healthcare stocks, benefiting from the performance of the healthcare sector as a whole, rather than relying on the performance of individual stocks. This ETF provides a convenient and cost-effective way to invest in the healthcare industry, including biotech and pharmaceutical companies, without having to purchase individual stocks.

Biotech ETF expense ratios

Biotech ETFs are a great way to invest in the biotech industry without the high risk associated with individual stocks. By investing in an ETF, you can benefit from diversification and lower portfolio volatility. While there are no Vanguard ETFs that focus specifically on biotechnology, the Vanguard Health Care ETF (NYSEMKT: VHT) does include some biotech stocks in its holdings. This ETF provides exposure to a range of healthcare stocks, including biotech and pharmaceutical manufacturers, medical device makers, insurance firms, and more.

When considering a biotech ETF, it is important to evaluate the expense ratio, which represents the cost of investing in the fund beyond the initial transaction charges. The expense ratio indicates the fund's operating expenses as a percentage of its average assets. Here are the expense ratios of some of the top biotech ETFs in the market:

• IShares Biotechnology ETF (IBB): This ETF has an expense ratio of 0.45%, which is relatively low compared to similar funds. It tracks the NYSE Biotechnology Index and has a diverse range of holdings, including some of the biggest names in biotech.
• SPDR S&P Biotech ETF (XBI): With an expense ratio of 0.35%, this ETF offers exposure to large-cap, mid-cap, and small-cap biotech stocks by tracking the S&P Biotechnology Select Industry Index. It provides a balanced approach and is known for its low costs.
• VanEck Biotech ETF (BBH): Charging an expense ratio of 0.35%, BBH is known for its focus on large and liquid US biotech firms, reducing risk for investors. It tends to favour the biggest companies in the biotech sector.
• Invesco Nasdaq Biotechnology ETF (IBBQ): IBBQ stands out with its low expense ratio of 0.19%, making it a cost-effective option for long-term investors. It tracks the Nasdaq Biotechnology Index and provides access to a substantial roster of biotech stocks.
• Global X Genomics & Biotechnology ETF (GNOM): This ETF has an expense ratio of 0.5%. It takes a broader approach by investing in a pool of biotech firms, reducing the risk associated with clinical trial outcomes.
• WisdomTree BioRevolution Fund (WDNA): With an expense ratio of 0.45%, WDNA complements core portfolios with innovative megatrends in the biotech space. It is less large-cap-heavy compared to some other ETFs and offers global diversification.

These expense ratios are important to consider when deciding which biotech ETF to invest in, as they impact your overall returns. It is worth noting that while lower expense ratios are generally favourable, other factors such as fund performance, holdings, and investment objectives should also be considered when making investment decisions.

Vanguard Health Care ETF holdings

The Vanguard Health Care ETF (VHT) tracks the entire spectrum of healthcare stocks, including biotech and pharmaceutical manufacturers, medical device makers, benefits managers, insurance firms, services and distributors, and even medical real estate owners. The ETF seeks to replicate the performance of the MSCI US Investable Market Index (IMI)/Health Care 25/50, which is made up of stocks from large, mid-size, and small US healthcare companies.

The ETF's top holdings include UnitedHealth Group Inc, Johnson & Johnson, Thermo Fisher Scientific Inc, and Abbott Laboratories. It also holds stocks from other sectors, including basic materials, communication services, consumer cyclical, and consumer defensive.

VHT offers exposure to the full range of market caps and provides investors with diversified access to the healthcare sector, including biotech and pharmaceutical companies. It is worth noting that the list of holdings may not be exhaustive, as newly issued ETFs may not be included.

Frequently asked questions